Skip to content

Study · Measured the body's own peptide · 2006

1 result

Mass spectrometric proteomics profiles of in vivo tumor secretomes: capillary ultrafiltration sampling of regressive tumor masses.

Huang CM, Ananthaswamy HN, Barnes S, Ma Y, Kawai M, Elmets CA

Proteomics1 Nov 2006Cited by 60 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01AnimalEndogenous levelAnimal study (in vivo)Other

    In mice with UV-induced fibrosarcoma, the body's own thymosin beta‑4 was identified among secreted proteins of tumor masses at the progressive stage.

    In plain wordsIn mice with tumors, the body's own thymosin beta‑4 was found in fluid from growing tumors.

    Outcome
    Not applicableThymosin beta 4 in progressive-stage tumor secretome
    Study

    mousen: not reported in source

    UV-2240 fibrosarcoma tumor masses
    Outcome group
    Endogenous peptide levels · Cancer

    Source sentences

    Summary
    Five secreted proteins (cyclophilin-A, S100A4, profilin-1, thymosin beta 4 and 10), previously associated with tumor progression, were identified from tumor masses at the progressive stage.
    1 context sentence
    Summary · context
    A UV-induced skin fibrosarcoma cell line (UV-2240) was subcutaneously injected into C3H/NeH mice, resulting in tumor masses that initially progressed, then regressed and eventually eradicated.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.